Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1996
05/08/1996CN1121919A 5-membered heteroaryl-oxazoli-dinones
05/08/1996CN1121832A Anticancer drug
05/08/1996CN1121806A Pharmaceutical agents for treatment of emesis
05/08/1996CN1031754C Process for preparing dithiane
05/08/1996CA2161936A1 New 1,5-disubstituted 7a-methylperhydroinden-3a-01 derivates, active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
05/07/1996USRE35233 Administering glutamine
05/07/1996US5514816 Reaction of difluorobenzo-1,3-dioxole with metal compounds for insecticides
05/07/1996US5514815 Succinimide derivatives and process for preparing the same
05/07/1996US5514808 Hydroxyl ions as unique therapeutic agents and compounds that modulate these ions
05/07/1996US5514803 Cardiovascular circulatory disorders
05/07/1996US5514802 Intermediates for preparing HIV protease inhibitors
05/07/1996US5514801 Cyclic sulfone containing retroviral protease inhibitors
05/07/1996US5514786 Compositions for inhibiting RNA activity
05/07/1996US5514778 Anti-picornaviral agents
05/07/1996US5514777 Methods of synthesis of peptidyl argininals
05/07/1996US5514720 Stable emulsions of highly fluorinated organic compounds
05/07/1996US5514718 Amino compounds with alkoxy, hydroxy, ketone or oxime groups for psychological disorders or tachykinin antagonist
05/07/1996US5514716 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
05/07/1996US5514715 Amino cyclopentanecarboxylic acid, fungicide
05/07/1996US5514714 Methods and polycyclic aromatic compound containing compositions for treating T-cell-mediated diseases
05/07/1996US5514712 Use of oils of chaulmoogra in the cosmetic and pharmaceutical domain, particularly in dermatology, for harmonizing pigmentation of the skin
05/07/1996US5514711 Styrene derivatives
05/07/1996US5514709 Lipidic furans and retinol palmitate compositions useful for skin therapeutics
05/07/1996US5514707 Inhibition of smooth muscle cell proliferation by 8-methoxypsoralen photoactivated by visible light
05/07/1996US5514706 Diabetes
05/07/1996US5514704 Benzothiophenes to inhibit leukotrienes
05/07/1996US5514703 Benzothiophene compounds useful for inhibiting lipoxygenase
05/07/1996US5514702 Arylamidoalkyl-N-hydroxyurea compounds having lipoxygenase inhibitory activity
05/07/1996US5514700 Substituted 1,2,3,4-tetrahydrocyclopent b!indoles, compositions and use
05/07/1996US5514699 Pharmaceutical compounds
05/07/1996US5514698 Antifungal vaginal cream composition
05/07/1996US5514696 Isoxazole moiety attached to n; used to treat hypertension, cell disorders and growth, endotoxemia and ischemia
05/07/1996US5514695 Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment
05/07/1996US5514690 Potassium channel activators, antiischemic, antiarrhythmic
05/07/1996US5514688 Carbocyclic adenosine analogs useful as immunosuppressants
05/07/1996US5514687 Benzopyrido piperidylidene compounds, compositions, methods of manufacture and method of use
05/07/1996US5514686 Use of macrolide compounds for eye diseases
05/07/1996US5514685 Antiinflammatory antoproliferative agents, immunosuppressants
05/07/1996US5514682 Fused imidazole and triazole derivatives as 5-HT1 receptor agonists
05/07/1996US5514680 Glycine receptor antagonists and the use thereof
05/07/1996US5514677 Hydroxamic acid based collagenase inhibitors
05/07/1996US5514676 Amino-benzoic acids and derivatives, and methods of use
05/07/1996US5514675 Naphthyl bradykinin receptor antagonists
05/07/1996US5514673 Pharmaceutical composition containing lipophilic drugs
05/07/1996US5514672 Use of retinoids and compositions containing same for hair growth
05/07/1996US5514671 Serine alkyl, cyclohexyl or aromatic ethers in vehicle; suppressing body odor by applying to skin
05/07/1996US5514668 Crown ether attached to polysaccharide, demetallization, removal of viruses, ammonia, amines
05/07/1996US5514667 Method for topical treatment of herpes infections
05/07/1996US5514665 Especially for cystic fibrosis patients
05/07/1996US5514664 Antitumor chemotherapy
05/07/1996US5514663 Laxitive
05/07/1996US5514662 Hiv infections
05/07/1996US5514661 Autoimmune disease treatment
05/07/1996US5514660 Method for treating and inhibiting gastric and duodenal ulcers
05/07/1996US5514659 3-deoxy oligosaccharides and pharmaceutical compositions containing them
05/07/1996US5514657 Wound healing, silver sulfadiazine, collagen
05/07/1996US5514649 Animal growth regulators; treating gramnegative and grampositive bacterial infections
05/07/1996US5514591 Method for measuring the ability of a yeast cell extract to influence oxygen respiration
05/07/1996US5514577 Oligonucleotide therapies for modulating the effects of herpes viruses
05/07/1996US5514536 Solutions for tissue preservation and bloodless surgery and methods using same
05/07/1996US5514398 Removing cholesterol by adding rice bran components and/or their derivatives to cholesterol-containing food to form a complex, and removing the complex; the complex; food formed by removing cholesterol in such a way
05/07/1996US5514383 Process for the preparation of tablets of derivatives of cephalosporanic acid by direct compression
05/07/1996US5514377 In situ dissolution of alginate coatings of biological tissue transplants
05/07/1996US5514370 High dosage topical forms of collagenase
05/07/1996US5513661 Use of sympathetic blockade for treatment of chronic muscle pain
05/07/1996CA2099565C N-hydroxyurea derivatives as antiallergy and antiinflammatory agents
05/07/1996CA2075551C Treatment of periodontitis
05/07/1996CA2014157C Antiparasitic formulation containing 25-cyclohexyl-avermectin b1
05/05/1996CA2162075A1 Modified oligonucleotides, their preparation and their use
05/04/1996CA2159850A1 Phosphonosulfonate squalene synthetase inhibitor salts and method
05/03/1996CA2161944A1 Oxazolidinedione derivatives, their production and use
05/03/1996CA2160423A1 Salts of nefazodone having improved dissolution rates
05/02/1996WO1996012817A1 Combination method for acne treatment
05/02/1996WO1996012797A1 Production and use of human and plant methyltransferases
05/02/1996WO1996012790A1 Microbial synthesis of hiv protease inhibitors
05/02/1996WO1996012728A1 L-pyranosyl nucleosides
05/02/1996WO1996012727A1 Water-soluble epipodophyllotoxin derivatives, preparation method therefor, and use thereof as a drug and for treating cancer
05/02/1996WO1996012724A1 Novel quinoxalindione derivatives, their production and use in medicaments
05/02/1996WO1996012720A1 Bicyclic tetrahydro pyrazolopyridines and their use as medicaments
05/02/1996WO1996012719A1 Quinoline derivative
05/02/1996WO1996012716A1 Nucleoside derivatives and process for preparing thereof
05/02/1996WO1996012715A1 Cyclopropachromenecarboxylate derivatives
05/02/1996WO1996012711A1 Heterocyclic compounds and their use
05/02/1996WO1996012710A1 Di-tert-butylphenol compounds with heterocyclic moiety, useful as anti-inflammatory agents
05/02/1996WO1996012705A1 7-substituted 4-aza cholanic acid derivatives and their use
05/02/1996WO1996012697A2 Calcium receptor-active compounds
05/02/1996WO1996012696A1 Salts of omega-3-polyunsaturated fatty acids and pharmaceutical formulations containing them
05/02/1996WO1996012508A2 Combined use of nucleoside analogues and gene transfection for tissue imaging and therapy
05/02/1996WO1996012498A2 Dermatological compositions containing benzoyl peroxide and a compound reducing skin irritation
05/02/1996WO1996012497A1 Use of 2'-substituted oligonucleotides to down-regulating gene expression
05/02/1996WO1996012496A1 Use of n-[(1s,trans)-2-hydroxycyclopentyl]-adenosine for reducing myocardial injury
05/02/1996WO1996012495A1 Percutaneously administrable preparation
05/02/1996WO1996012494A1 Competitive progesterone antagonists for regulating female fertility as required
05/02/1996WO1996012493A1 Absorption enhancer/solubilizer combination for improved bioavailability of a zwitterionic compound
05/02/1996WO1996012492A1 Microbial synthesis of hiv protease inhibitors
05/02/1996WO1996012491A1 Method of inhibiting conditions associated with bradykinin
05/02/1996WO1996012490A1 Methods of inhibiting conditions associated with neuropeptide y
05/02/1996WO1996012489A1 Bicyclic neuropeptide y receptor antagonists
05/02/1996WO1996012488A1 Bicyclic bradykinin receptor antagonists
05/02/1996WO1996012487A1 Combination method for acne treatment
1 ... 6920 6921 6922 6923 6924 6925 6926 6927 6928 6929 6930 6931 6932 6933 6934 6935 6936 6937 6938 6939 6940 ... 7860